Operationalising disease modification in obesity trials: A blueprint based on the <scp>SYNCHRONIZE</scp> ‐1 survodutide study

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2025-12-22
DOI
https://doi.org/10.1111/dom.70407
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Operationalising disease modification in obesity trials: A blueprint based on the SYNCHRONIZE ‐1 survodutide study

Jiayuan Huang, Baodong Wang, Zhiyun Chen
Diabetes Obesity and Metabolism
Pharmacology and Obesity Treatment
article

Operationalising disease modification in obesity trials: A blueprint based on the SYNCHRONIZE ‐1 survodutide study

Jiayuan Huang, Baodong Wang, Zhiyun Chen
article en

Abstract

No abstract available for this paper.
Diabetes Obesity and MetabolismVol. 28(3)
Zhejiang Chinese Medical University (CN), Hangzhou Red Cross Hospital (CN)
Zero hunger
Openalex Percentile: Top 31%
Pharmacology and Obesity Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Operationalising disease modification in obesity trials: A blueprint based on the <scp>SYNCHRONIZE</scp> ‐1 survodutide study — Jiayuan Huang, Baodong Wang, et al. · Diabetes Obesity and Metabolism (2025) | TGRS Research Map | TGRS